BEAR Implant
Acute, proximal Anterior Cruciate Ligament (ACL) tears
Key Facts
About Miach Orthopaedics
Miach Orthopaedics is a commercial-stage medical device company pioneering a paradigm shift in ACL treatment with its BEAR (Bridge-Enhanced ACL Repair) Implant. Unlike traditional ACL reconstruction (ACLR), which replaces the torn ligament with a graft, the BEAR Implant is a bioresorbable scaffold that, when combined with a small amount of the patient's blood, creates an environment to facilitate the native ACL's healing. Supported by Level 1 clinical evidence, the implant received FDA approval in 2020 and is now available across the United States, offering potential benefits such as preserved native anatomy, better hamstring strength recovery, and a reduced trend in contralateral tears. The company is actively conducting post-market studies to build its long-term evidence base.
View full company profile